首页 > 最新文献

International Journal of Ayurveda and Pharma Research最新文献

英文 中文
An Ayurvedic Perspective About Duchenne Muscular Dystrophy 关于杜兴氏肌肉萎缩症的阿育吠陀观点
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3156
Ashwini A. Patil, Rutuja Rahul Kate
Duchenne muscular dystrophy is a neuromuscular disease. This is an X-linked recessive disease caused by mutations in the dystrophin protein gene located on the short arm of the X chromosome, in the Xp21 region. It causes progressive muscle weakness due to wasting of muscle fibers. It causes loss of ability to stand, walk, and move before age 10; most patients die in their 20s. Since there is no specific treatment in any medical system and the prognosis of the disease is uncertain, if we start treatment at an early stage, children with DMD can walk, it can slow or stop progressive muscle degeneration. DMD cannot be directly related to a single disease in Ayurveda. Most major neuromuscular disorders are determined by Vata dosha. In Ayurveda, this pathogenesis can be clearly understood by the concept of Adibala Pravrutta Vyadhi (genetic disease). Here the pathogenesis is due to Beeja Bhagavayava Dusti (partial chromosomal defect) leading to Mamsa Vata Dushti.
杜氏肌营养不良症是一种神经肌肉疾病。这是一种 X 连锁隐性遗传病,由位于 X 染色体短臂 Xp21 区域的肌营养蛋白基因突变引起。由于肌纤维萎缩,它会导致进行性肌无力。这种病会导致患者在 10 岁前丧失站立、行走和移动的能力;大多数患者在 20 多岁时死亡。由于目前尚无特效治疗方法,该病的预后也不确定,但如果我们在早期就开始治疗,DMD 患儿就可以行走,可以减缓或阻止进行性肌肉退化。在阿育吠陀中,DMD 无法与单一疾病直接相关。大多数主要的神经肌肉疾病都是由瓦塔体质(Vata dosha)决定的。在阿育吠陀中,"Adibala Pravrutta Vyadhi"(遗传病)的概念可以清楚地解释这种发病机制。这里的发病机制是由于 Beeja Bhagavayava Dusti(部分染色体缺陷)导致 Mamsa Vata Dushti。
{"title":"An Ayurvedic Perspective About Duchenne Muscular Dystrophy","authors":"Ashwini A. Patil, Rutuja Rahul Kate","doi":"10.47070/ijapr.v12i3.3156","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3156","url":null,"abstract":"Duchenne muscular dystrophy is a neuromuscular disease. This is an X-linked recessive disease caused by mutations in the dystrophin protein gene located on the short arm of the X chromosome, in the Xp21 region. It causes progressive muscle weakness due to wasting of muscle fibers. It causes loss of ability to stand, walk, and move before age 10; most patients die in their 20s. Since there is no specific treatment in any medical system and the prognosis of the disease is uncertain, if we start treatment at an early stage, children with DMD can walk, it can slow or stop progressive muscle degeneration. DMD cannot be directly related to a single disease in Ayurveda. Most major neuromuscular disorders are determined by Vata dosha. In Ayurveda, this pathogenesis can be clearly understood by the concept of Adibala Pravrutta Vyadhi (genetic disease). Here the pathogenesis is due to Beeja Bhagavayava Dusti (partial chromosomal defect) leading to Mamsa Vata Dushti.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"12 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140743969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutico-Analytical Study of Tamboola Arka Tamboola Arka 的药物分析研究
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3167
Anjana R A, R Rajam
Arka Kalpana is a distinctive Ayuvedic pharmaceutical preparation in which the active principles and volatile components of a drug are extracted with the help of Arka yanthra or another practical modern distillation apparatus. Tamboola Arka is a preparation mentioned in third Shataka of Arka Prakasha. It has properties to cure the Mukha dourgandhya, Mala, Vata and Srama nashana. Tamboola pathra has Katu, Tikta, Kashaya rasa and Laghu, Tikshna Vishada gunas by which it can be used to control the diseases which occur inside the mouth. Since it is an Arka preparation it has got several benefits like shelf life and is also user friendly. No previous works have been carried out on Tamboola Arka. So in this study Tamboola Arka was prepared and organoleptic and physico-chemical parameters were tested. GCMS (Gas Chromatography and Mass Spectrometry) was also conducted to identify the various components and their concentrations.
Arka Kalpana 是一种独特的阿育吠陀药剂,借助 Arka yanthra 或其他实用的现代蒸馏设备提取药物的活性成分和挥发性成分。Tamboola Arka 是 Arka Prakasha 第三章 Shataka 中提到的一种制剂。它具有治疗 Mukha dourgandhya、Mala、Vata 和 Srama nashana 的特性。Tamboola pathra 具有 Katu、Tikta、Kashaya rasa 和 Laghu、Tikshna Vishada 等属性,可用于控制口腔内的疾病。由于它是一种 Arka 制剂,因此具有保质期长、使用方便等优点。以前没有人对 Tamboola Arka 进行过研究。因此,本研究制备了 Tamboola Arka,并对其感官和理化参数进行了测试。此外,还进行了气相色谱和质谱分析,以确定各种成分及其浓度。
{"title":"Pharmaceutico-Analytical Study of Tamboola Arka","authors":"Anjana R A, R Rajam","doi":"10.47070/ijapr.v12i3.3167","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3167","url":null,"abstract":"Arka Kalpana is a distinctive Ayuvedic pharmaceutical preparation in which the active principles and volatile components of a drug are extracted with the help of Arka yanthra or another practical modern distillation apparatus. Tamboola Arka is a preparation mentioned in third Shataka of Arka Prakasha. It has properties to cure the Mukha dourgandhya, Mala, Vata and Srama nashana. Tamboola pathra has Katu, Tikta, Kashaya rasa and Laghu, Tikshna Vishada gunas by which it can be used to control the diseases which occur inside the mouth. Since it is an Arka preparation it has got several benefits like shelf life and is also user friendly. No previous works have been carried out on Tamboola Arka. So in this study Tamboola Arka was prepared and organoleptic and physico-chemical parameters were tested. GCMS (Gas Chromatography and Mass Spectrometry) was also conducted to identify the various components and their concentrations.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"28 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140743942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Efficacy and Safety of Eye Mantra Drops: A Comprehensive Post-Marketing Surveillance Study in Ocular Disorders 评估眼药水 Mantra 的疗效和安全性:眼部疾病上市后综合监测研究
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3090
Shreya Verma, Amrish Verma, Jaspal Singh, Hasan Ali Ahmed, Chetan Jaykar
Objectives: This study aimed to systematically evaluate the efficacy and safety of Eye Mantra Drops, a modern formulation integrating ayurvedic principles and medicinal plant extracts, in addressing various ocular conditions, including conjunctivitis, iritis, dry eyes, eye strain, itchiness, and watery eyes. Methods: The study adopted a single-center, open-label, non-randomized, post-marketing surveillance approach, involving 120 subjects with diverse ocular conditions. Eye Mantra Drops, comprising thirteen traditionally used ingredients, were administered to the participants for 7 days. Frequency and severity of symptoms, vital signs, and adverse events were assessed at screening and at the end of study to evaluate the safety and efficacy of Eye Mantra Drops. Results: The study revealed a significant reduction in frequency and symptom severity across diverse ocular conditions, including conjunctivitis, iritis, dry eyes, itchiness, watery eyes, and eye strain. No adverse events were reported, and vital signs remained stable, indicating the safety of Eye Mantra Drops. Conclusion: Eye Mantra Drops emerged as a promising and well-tolerated intervention for various ocular conditions including conjunctivitis, iritis, dry eyes, eye strain, itchiness, and watery eyes.
研究目的本研究旨在系统评估眼部曼陀罗滴眼液的疗效和安全性。眼部曼陀罗滴眼液是一种融合了阿育吠陀医学原理和药用植物提取物的现代配方,可用于治疗各种眼部疾病,包括结膜炎、虹膜炎、干眼症、眼疲劳、眼痒和流泪。研究方法研究采用单中心、开放标签、非随机、上市后监测的方法,涉及 120 名患有各种眼部疾病的受试者。受试者连续 7 天服用由 13 种传统成分组成的眼药水。在筛选和研究结束时对症状的频率和严重程度、生命体征和不良事件进行评估,以评价 Eye Mantra Drops 的安全性和有效性。研究结果研究显示,结膜炎、虹膜炎、眼干、眼痒、流泪和眼疲劳等各种眼部症状的发生频率和严重程度都有明显降低。没有不良反应报告,生命体征保持稳定,这表明 Eye Mantra Drops 是安全的。结论眼咒滴眼液对结膜炎、虹膜炎、干眼症、眼疲劳、眼痒和流泪等各种眼部疾病具有良好的治疗效果和耐受性。
{"title":"Evaluating the Efficacy and Safety of Eye Mantra Drops: A Comprehensive Post-Marketing Surveillance Study in Ocular Disorders","authors":"Shreya Verma, Amrish Verma, Jaspal Singh, Hasan Ali Ahmed, Chetan Jaykar","doi":"10.47070/ijapr.v12i3.3090","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3090","url":null,"abstract":"Objectives: This study aimed to systematically evaluate the efficacy and safety of Eye Mantra Drops, a modern formulation integrating ayurvedic principles and medicinal plant extracts, in addressing various ocular conditions, including conjunctivitis, iritis, dry eyes, eye strain, itchiness, and watery eyes. Methods: The study adopted a single-center, open-label, non-randomized, post-marketing surveillance approach, involving 120 subjects with diverse ocular conditions. Eye Mantra Drops, comprising thirteen traditionally used ingredients, were administered to the participants for 7 days. Frequency and severity of symptoms, vital signs, and adverse events were assessed at screening and at the end of study to evaluate the safety and efficacy of Eye Mantra Drops. Results: The study revealed a significant reduction in frequency and symptom severity across diverse ocular conditions, including conjunctivitis, iritis, dry eyes, itchiness, watery eyes, and eye strain. No adverse events were reported, and vital signs remained stable, indicating the safety of Eye Mantra Drops. Conclusion: Eye Mantra Drops emerged as a promising and well-tolerated intervention for various ocular conditions including conjunctivitis, iritis, dry eyes, eye strain, itchiness, and watery eyes.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"8 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140744261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report on Alcohol Withdrawal Syndrome 酒精戒断综合征病例报告
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3164
Divin V, Suneeshmon M S
Heavy drinkers who abruptly cut back on their alcohol intake or give it up entirely risk experiencing alcohol withdrawal. The warning signs and symptoms include agitation, anxiety, irritability, and mild to moderate tremors. Seizure, hallucinations, delirium tremens are the most severe withdrawal symptoms. These symptoms arise from abnormalities in brain chemistry brought on by alcohol, which leads to an excess of neuronal activity when the alcohol is stopped. Ayurveda is a holistic approach which not only takes body into consideration but also mental status. Madatyaya is a wide term explained in our classics, while explaining Madya, Acharaya told that it has properties opposite to that of Ojus, so these substances causing depletion to our body resources can be correlated to Madatyaya. So it’s a case report on alcohol withdrawal symptoms and its effective management using Ayurvedic treatment modalities.
酗酒者如果突然减少酒精摄入量或完全戒酒,就有可能出现酒精戒断。预警信号和症状包括激动、焦虑、易怒和轻度至中度震颤。癫痫发作、幻觉、震颤性谵妄是最严重的戒酒症状。这些症状源于酒精导致的大脑化学反应异常,当停止饮酒后会导致神经元活动过度。阿育吠陀是一种全面的方法,不仅考虑身体,还考虑精神状态。在我们的经典中,"Madatyaya "是一个宽泛的术语,在解释 "Madya "时,Acharaya 告诉我们,它具有与 "Ojus "相反的特性,因此这些导致身体资源枯竭的物质可以与 "Madatyaya "相关联。因此,这是一份关于酒精戒断症状的病例报告,以及使用阿育吠陀治疗方法有效控制酒精戒断症状的病例报告。
{"title":"A Case Report on Alcohol Withdrawal Syndrome","authors":"Divin V, Suneeshmon M S","doi":"10.47070/ijapr.v12i3.3164","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3164","url":null,"abstract":"Heavy drinkers who abruptly cut back on their alcohol intake or give it up entirely risk experiencing alcohol withdrawal. The warning signs and symptoms include agitation, anxiety, irritability, and mild to moderate tremors. Seizure, hallucinations, delirium tremens are the most severe withdrawal symptoms. These symptoms arise from abnormalities in brain chemistry brought on by alcohol, which leads to an excess of neuronal activity when the alcohol is stopped. Ayurveda is a holistic approach which not only takes body into consideration but also mental status. Madatyaya is a wide term explained in our classics, while explaining Madya, Acharaya told that it has properties opposite to that of Ojus, so these substances causing depletion to our body resources can be correlated to Madatyaya. So it’s a case report on alcohol withdrawal symptoms and its effective management using Ayurvedic treatment modalities.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"8 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140745151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Varieties of Classical Drug Kadamba 经典药物卡当巴的品种
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3174
Singh Sanjeev Kumar, Mishra Hari Shanker, Agarwal Ajay, Shukla Anil Kumar
Kadamb an indigenous plant described in classical texts of Ayurved has a wide range of therapeutic potential. In Charak Samhita, it has been classified in the group of drugs indicated in the management of pain (Vednasthapan Mahakashya). Among various indications, it has been reported to be used in the treatment of vitiated semen, as an astringent in healing of fractured wounds, hemorrhagic conditions, dyslipidaemia, diseases of female genital tract, as complexion promoting and alexipharmic. In classical texts, at least four varieties of Kadamb have been described. There has always been some controversy regarding botanical identity of different varieties of Kadamb described in classical texts. Present paper is a serious attempt towards establishment of botanical identities of different types of Kadamb described in classical text of Ayurved on the basis of exploration of literature substantiated by observations of field survey.
Kadamb 是阿育吠陀经典文献中描述的一种本土植物,具有广泛的治疗潜力。在《Charak Samhita》中,它被归类为治疗疼痛的药物(Vednasthapan Mahakashya)。在各种适应症中,它被报道用于治疗精液不液化,作为收敛剂用于骨折伤口的愈合、出血性疾病、血脂异常、女性生殖道疾病,还可用于改善肤色和祛斑。在古典文献中,至少描述了四种 Kadamb。对于古典文献中描述的不同品种的卡丹布的植物学特征,一直存在一些争议。本文是一次认真的尝试,旨在通过实地调查观察,在文献探索的基础上,确定阿育吠陀经典文献中描述的不同类型 Kadamb 的植物学特征。
{"title":"Varieties of Classical Drug Kadamba","authors":"Singh Sanjeev Kumar, Mishra Hari Shanker, Agarwal Ajay, Shukla Anil Kumar","doi":"10.47070/ijapr.v12i3.3174","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3174","url":null,"abstract":"Kadamb an indigenous plant described in classical texts of Ayurved has a wide range of therapeutic potential. In Charak Samhita, it has been classified in the group of drugs indicated in the management of pain (Vednasthapan Mahakashya). Among various indications, it has been reported to be used in the treatment of vitiated semen, as an astringent in healing of fractured wounds, hemorrhagic conditions, dyslipidaemia, diseases of female genital tract, as complexion promoting and alexipharmic. In classical texts, at least four varieties of Kadamb have been described. There has always been some controversy regarding botanical identity of different varieties of Kadamb described in classical texts. Present paper is a serious attempt towards establishment of botanical identities of different types of Kadamb described in classical text of Ayurved on the basis of exploration of literature substantiated by observations of field survey.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"2 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140743577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe Clinical Insomnia Management with Ayurvedic Protocol - A Case Report 用阿育吠陀疗法治疗严重临床失眠--病例报告
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3173
Shilpa Thengil, Ambili Krishna
Insomnia is characterized by inability to sleep or lack of sleep. Severe clinical insomnia is a highly prevalent health concern faced by a wide majority of people across the globe due to the rise in stressful external environments. Often such cases require long term use of sedative hypnotics or tranquilizers which are habit forming. Ayurveda identifies insomnia as Nidranasa and is a disease which is caused predominantly by Vata Pitta increase and a dip in Kapha levels. Ayurvedic treatment protocol involves internal medication and topical procedures like Shirodhara and Abhyanga. This case report is intended to throw light to a positive outcome of Ayurvedic treatment protocol in severe clinical insomnia. A 34-year-old male presented with symptoms of severe clinical insomnia assessed by Insomnia Severity Index (ISI) associated with obesity and had a history of consuming hypnotics. The treatment protocol included Dhanyamladhara, Udvartana, Takradhara, Abhyanga and Shirodhara along with disease specific internal medicines. The ISI score before treatment of 26 came down to 1 after treatment and was maintained during 3 months follow up. This displays the complete remission of the disease without the use of habit-forming internal medication.
失眠的特点是无法入睡或睡眠不足。由于外部环境压力的增加,严重的临床失眠是全球大多数人面临的一个非常普遍的健康问题。在这种情况下,往往需要长期使用镇静催眠药或镇定剂,而这些药物会形成习惯。阿育吠陀认为失眠是一种主要由 Vata Pitta 增加和 Kapha 水平下降引起的疾病。阿育吠陀治疗方案包括内服药和局部治疗,如 Shirodhara 和 Abhyanga。本病例报告旨在揭示阿育吠陀疗法对严重临床失眠症的积极疗效。一名 34 岁的男性出现了严重的临床失眠症状,根据失眠严重程度指数(ISI)评估,该症状与肥胖有关,并有服用催眠药的病史。治疗方案包括 Dhanyamladhara、Udvartana、Takradhara、Abhyanga 和 Shirodhara 以及针对特定疾病的内服药。治疗前的 ISI 分数为 26 分,治疗后降至 1 分,并在 3 个月的随访中保持不变。这表明,在不使用习惯性内服药的情况下,疾病得到了完全缓解。
{"title":"Severe Clinical Insomnia Management with Ayurvedic Protocol - A Case Report","authors":"Shilpa Thengil, Ambili Krishna","doi":"10.47070/ijapr.v12i3.3173","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3173","url":null,"abstract":"Insomnia is characterized by inability to sleep or lack of sleep. Severe clinical insomnia is a highly prevalent health concern faced by a wide majority of people across the globe due to the rise in stressful external environments. Often such cases require long term use of sedative hypnotics or tranquilizers which are habit forming. Ayurveda identifies insomnia as Nidranasa and is a disease which is caused predominantly by Vata Pitta increase and a dip in Kapha levels. Ayurvedic treatment protocol involves internal medication and topical procedures like Shirodhara and Abhyanga. This case report is intended to throw light to a positive outcome of Ayurvedic treatment protocol in severe clinical insomnia. A 34-year-old male presented with symptoms of severe clinical insomnia assessed by Insomnia Severity Index (ISI) associated with obesity and had a history of consuming hypnotics. The treatment protocol included Dhanyamladhara, Udvartana, Takradhara, Abhyanga and Shirodhara along with disease specific internal medicines. The ISI score before treatment of 26 came down to 1 after treatment and was maintained during 3 months follow up. This displays the complete remission of the disease without the use of habit-forming internal medication.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"19 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140741071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic Approach for Management of Secondary Infertility due to Artavakshaya (PCOD) 阿育吠陀疗法治疗阿尔塔瓦克夏亚(多囊卵巢综合症)引起的继发性不孕症
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3157
Nikita Bharghava, Bihani Sanjyal, K. Bharathi, Poonam Choudhary
The World Health Organization defines infertility as a disorder of the male or female reproductive system characterized by the inability to conceive after 12 months or more of consistent unprotected sexual activity. Secondary infertile if they have successfully became pregnant at least once in the past. 30-40% of infertility is caused by ovulatory disruption. PCOS is characterized by oligo/anovulation, excess androgen-related symptoms, and numerous ovarian cysts. Infertility correlates with Vandhyatha in Ayurveda. Acharya Harita described that failure to achieve a Praja known as Vandhayatwa. Praja is achieve by Garbha and to achieve Garbha purity of many component (Ritu, Kshetra, Ambu, Beeja) is necessary. Regarding this case, Ritu is disturbed in form of Artavkshaya, managed through principles like use of Agneya dravya, Agni Deepana, Vata Shamana and Piita Vardhna. Case presentation: A female patient, 25 years old, visited Prasuti Tantra and Stri- Roga OPD of National Institute of Ayurveda, Jaipur, on 28 august 2023 with secondary infertility associated with delayed and scanty menses for 3 years. Methodology: Detailed history with all clinical, physical examination and laboratory investigations were carried out which were normal. Ultrasonography reveals bilateral PCOD. So the treatment was planned accordingly. Patient was treated with Shatapushpa churna in 2 consecutive cycles. Result: Patient got her menstruation after one month of drug intake with improvement in menstrual pattern. She continued to take drug during the second month and missed her period consequently after that.UPT was done and was found positive
世界卫生组织将不孕症定义为男性或女性生殖系统的疾病,其特征是持续 12 个月或更长时间的无保护性活动后仍无法受孕。如果过去至少成功怀孕过一次,则为继发性不孕。30%-40%的不孕症是由排卵障碍引起的。多囊卵巢综合症的特点是少/无排卵、雄激素相关症状过多和卵巢囊肿多。在阿育吠陀中,不孕症与 Vandhyatha 相关。阿查里亚-哈里塔(Acharya Harita)将未能实现 "般若"(Praja)的情况称为 "梵天"(Vandhayatwa)。Praja是通过Garbha来实现的,而要实现Garbha,必须要有纯净的成分(Ritu、Kshetra、Ambu、Beeja)。在本案例中,Ritu 以 Artavkshaya 的形式受到干扰,通过使用 Agneya dravya、Agni Deepana、Vata Shamana 和 Piita Vardhna 等原则进行管理。病例介绍:一位 25 岁的女性患者于 2023 年 8 月 28 日到斋浦尔国家阿育吠陀研究所的 Prasuti Tantra 和 Stri- Roga 门诊就诊,她患有继发性不孕症,伴有 3 年的月经延迟和稀少。治疗方法详细询问病史,进行所有临床、体格检查和实验室检查,结果均正常。超声波检查显示双侧多囊卵巢综合症。因此制定了相应的治疗计划。患者接受了连续两个周期的 Shatapushpa churna 治疗。结果:患者服药一个月后月经来潮,月经模式有所改善。她在第二个月继续服药,之后月经就没来了。
{"title":"Ayurvedic Approach for Management of Secondary Infertility due to Artavakshaya (PCOD)","authors":"Nikita Bharghava, Bihani Sanjyal, K. Bharathi, Poonam Choudhary","doi":"10.47070/ijapr.v12i3.3157","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3157","url":null,"abstract":"The World Health Organization defines infertility as a disorder of the male or female reproductive system characterized by the inability to conceive after 12 months or more of consistent unprotected sexual activity. Secondary infertile if they have successfully became pregnant at least once in the past. 30-40% of infertility is caused by ovulatory disruption. PCOS is characterized by oligo/anovulation, excess androgen-related symptoms, and numerous ovarian cysts. Infertility correlates with Vandhyatha in Ayurveda. Acharya Harita described that failure to achieve a Praja known as Vandhayatwa. Praja is achieve by Garbha and to achieve Garbha purity of many component (Ritu, Kshetra, Ambu, Beeja) is necessary. Regarding this case, Ritu is disturbed in form of Artavkshaya, managed through principles like use of Agneya dravya, Agni Deepana, Vata Shamana and Piita Vardhna. Case presentation: A female patient, 25 years old, visited Prasuti Tantra and Stri- Roga OPD of National Institute of Ayurveda, Jaipur, on 28 august 2023 with secondary infertility associated with delayed and scanty menses for 3 years. Methodology: Detailed history with all clinical, physical examination and laboratory investigations were carried out which were normal. Ultrasonography reveals bilateral PCOD. So the treatment was planned accordingly. Patient was treated with Shatapushpa churna in 2 consecutive cycles. Result: Patient got her menstruation after one month of drug intake with improvement in menstrual pattern. She continued to take drug during the second month and missed her period consequently after that.UPT was done and was found positive","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"14 21-22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140744317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unraveling the Ayurvedic Protocol in the Management of Ranula 揭开阿育吠陀疗法治疗拉努拉病的神秘面纱
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3170
Negi Sangyasri, Negi Aman, Sharma Shushmita
Shalakya tantra is the branch of Ayurveda which deals with Urdhwajatrugata rogas i.e., diseases occurring in supraclavicular region. Acharyas have mentioned various Mukharogas (diseases pertaining to oral cavity) which are further subdivided into various categories. Acharya Sushruta has mentioned five Jihwagata rogas (diseases of tongue) and their management. Upajihwika which is caused by vitiation of Kapha and Rakta, is the Jihwagraroopa shwathu cystic swelling under the ventral aspect of tongue. In modern, it can be correlated with Ranula which is a translucent swelling in the floor of the mouth formed due to sublingual gland trauma or obstruction of the ducts. It further leads to extravasation and accumulation of saliva in the surrounding tissue thus forming a cyst. Case and Intervention- A 49-year-old male patient presented to ENT OPD of Patanjali Ayurveda Hospital with swelling in left submandibular region for 2 months. There was no difficulty in mastication and swallowing with no history of trauma. The patient was diagnosed with plunging Ranula sized 4x3 cm based on USG findings. He underwent three months and 10 days course of Ayurvedic regime and two follow ups showing reduction in size of the cystic swelling. Conclusion: Several surgical techniques have been introduced to treat Ranula ranging from marsupialization, excision of Ranula, excision of sublingual glands, sclerotherapy with varying success and recurrence rate. Ayurvedic protocol aimed at holistic approach by pacifying the vitiated Doshas and showing marked regression in the cystic growth without making the patient undergo the pain and high cost and adverse effect as that of a surgical procedure.
Shalakya tantra 是阿育吠陀的一个分支,主要治疗 Urdhwajatrugata rogas,即发生在锁骨上区域的疾病。阿查里亚提到了各种 Mukharogas(与口腔有关的疾病),这些疾病又被细分为不同的类别。阿查里亚-苏什鲁塔(Acharya Sushruta)提到了五种舌头疾病(Jihwagata rogas)及其治疗方法。Upajihwika 由 Kapha 和 Rakta 败坏引起,是舌腹下的 Jihwagraroopa shwathu 囊肿。在现代医学中,它可以与 Ranula 相关联,后者是由于舌下腺创伤或导管阻塞而在口腔底部形成的半透明肿物。它会进一步导致唾液外渗并积聚在周围组织中,从而形成囊肿。病例和干预措施--一名 49 岁的男性患者因左侧颌下腺肿胀 2 个月来到帕坦伽利阿育吠陀医院耳鼻喉科手术室就诊。患者没有咀嚼和吞咽困难,也没有外伤史。根据 USG 检查结果,患者被诊断为大小为 4x3 厘米的暴发性兰努拉。他接受了三个月零十天的阿育吠陀疗法治疗,两次随访显示囊性肿物缩小。结论目前已经引入了多种手术技术来治疗瘤囊肿,包括瘤囊肿切除术、瘤囊肿切除术、舌下腺切除术和硬化疗法,但成功率和复发率各不相同。阿育吠陀疗法的目的是通过安抚虚弱的多沙症(Doshas)来达到整体治疗的目的,并显示囊性增生明显消退,而不会让患者承受手术带来的痛苦、高昂费用和不良影响。
{"title":"Unraveling the Ayurvedic Protocol in the Management of Ranula","authors":"Negi Sangyasri, Negi Aman, Sharma Shushmita","doi":"10.47070/ijapr.v12i3.3170","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3170","url":null,"abstract":"Shalakya tantra is the branch of Ayurveda which deals with Urdhwajatrugata rogas i.e., diseases occurring in supraclavicular region. Acharyas have mentioned various Mukharogas (diseases pertaining to oral cavity) which are further subdivided into various categories. Acharya Sushruta has mentioned five Jihwagata rogas (diseases of tongue) and their management. Upajihwika which is caused by vitiation of Kapha and Rakta, is the Jihwagraroopa shwathu cystic swelling under the ventral aspect of tongue. In modern, it can be correlated with Ranula which is a translucent swelling in the floor of the mouth formed due to sublingual gland trauma or obstruction of the ducts. It further leads to extravasation and accumulation of saliva in the surrounding tissue thus forming a cyst. Case and Intervention- A 49-year-old male patient presented to ENT OPD of Patanjali Ayurveda Hospital with swelling in left submandibular region for 2 months. There was no difficulty in mastication and swallowing with no history of trauma. The patient was diagnosed with plunging Ranula sized 4x3 cm based on USG findings. He underwent three months and 10 days course of Ayurvedic regime and two follow ups showing reduction in size of the cystic swelling. Conclusion: Several surgical techniques have been introduced to treat Ranula ranging from marsupialization, excision of Ranula, excision of sublingual glands, sclerotherapy with varying success and recurrence rate. Ayurvedic protocol aimed at holistic approach by pacifying the vitiated Doshas and showing marked regression in the cystic growth without making the patient undergo the pain and high cost and adverse effect as that of a surgical procedure.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"37 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140746369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Shatavarichinnaruhadi Ksheerakasaya in Perimenopausal Symptoms Shatavarichinnaruhadi Ksheerakasaya 对围绝经期症状的影响
Pub Date : 2024-04-04 DOI: 10.47070/ijapr.v12i3.3160
Thasneem K K, Giby Thomas, Maya Balakrishnan
Menopause is referred to as Rajakshaya in Ayurveda, which is the body's transition from a Pitta- to a Vata-dominant condition. It comes under Swabhavika vyadhi and occurs in Jara pakwa sareera, which causes Dhatus to gradually deteriorate. Treatment of perimenopausal symptoms may benefit from medications with Rasayana, Medhya, Balya, Dahasamana, Vayasthapaka, and Rasarakthaprasadaka characteristics. A 44-year-old woman who sought treatment for hot flushes, excessive sweating, particularly at night, irritability, mood swings, numbness in the extremities, sleep disturbances, and vaginal itching is presented here. Assessment was done using Greene Climacteric Scale. Among all the symptoms, hot flushes and night sweats were the most distressing one for the subject. Shatavari chinnaruhadiksheerakasaya mentioned in Chikitsamanjari in Vataraktha context possess Vatapittapradhana Tridoshasamana, Rasarakthapradhaka, Dahasamana, Rasayana, Medhya, Balya like properties which can be beneficial in reducing the most wretched vasomotor symptoms. Apart from these, the formulation exhibits anti-oxidant, free radical scavenging, phytoestrogenic and anti-stress activity. Ksheera is Vata pitta samana, Rasayana, Sheeta veerya, Vrishya, Ojasyam, Dhatuvardhaka, and Jeevaneeya. For thirty days, 48ml of Shatavarichinnaruhadi ksheerakasaya was administered twice daily, one hour before food. The severity of symptoms particularly hot flushes and night sweats were considerably reduced after treatment. Thirty days after quitting the drug, a follow-up was conducted, and this time the severity of the symptoms was also less severe than it had been before therapy. From this case report, it is evident that Shatavarichinnaruhadi ksheerakasaya is effective for the management of perimenopausal symptoms especially the most disturbing vasomotor symptoms
更年期在阿育吠陀中被称为 "Rajakshaya",是身体从 Pitta 主导状态向 Vata 主导状态的过渡。它属于 Swabhavika vyadhi,发生在 Jara pakwa sareera,会导致 Dhatus 逐渐恶化。具有 Rasayana、Medhya、Balya、Dahasamana、Vayasthapaka 和 Rasarakthaprasadaka 特性的药物可用于围绝经期症状的治疗。本文介绍了一位因潮热、多汗(尤其是夜间)、易怒、情绪波动、四肢麻木、睡眠障碍和阴道瘙痒而寻求治疗的 44 岁女性。评估采用格林 Climacteric 量表。在所有症状中,潮热和盗汗是最令受试者痛苦的症状。Chikitsamanjari 中提到的 Shatavari chinnaruhadiksheerakasaya 在 Vataraktha 背景下具有 Vatapittapradhana Tridoshasamana、Rasarakthapradhaka、Dahasamana、Rasayana、Medhya、Balya 等特性,这些特性有助于减轻最痛苦的血管运动症状。除此之外,该配方还具有抗氧化、清除自由基、植物雌激素和抗应激的活性。Ksheera 是 Vata pitta samana、Rasayana、Sheeta veerya、Vrishya、Ojasyam、Dhatuvardhaka 和 Jeevaneeya。连续三十天,每天两次,每次 48 毫升,饭前一小时服用 Shatavarichinnaruhadi ksheerakasaya。治疗后,症状的严重程度,尤其是潮热和盗汗明显减轻。停药 30 天后进行了随访,这次症状的严重程度也比治疗前有所减轻。从本病例报告中可以看出,Shatavarichinnaruhadi ksheerakasaya 能有效治疗围绝经期症状,尤其是最令人不安的血管运动症状。
{"title":"Effect of Shatavarichinnaruhadi Ksheerakasaya in Perimenopausal Symptoms","authors":"Thasneem K K, Giby Thomas, Maya Balakrishnan","doi":"10.47070/ijapr.v12i3.3160","DOIUrl":"https://doi.org/10.47070/ijapr.v12i3.3160","url":null,"abstract":"Menopause is referred to as Rajakshaya in Ayurveda, which is the body's transition from a Pitta- to a Vata-dominant condition. It comes under Swabhavika vyadhi and occurs in Jara pakwa sareera, which causes Dhatus to gradually deteriorate. Treatment of perimenopausal symptoms may benefit from medications with Rasayana, Medhya, Balya, Dahasamana, Vayasthapaka, and Rasarakthaprasadaka characteristics. A 44-year-old woman who sought treatment for hot flushes, excessive sweating, particularly at night, irritability, mood swings, numbness in the extremities, sleep disturbances, and vaginal itching is presented here. Assessment was done using Greene Climacteric Scale. Among all the symptoms, hot flushes and night sweats were the most distressing one for the subject. Shatavari chinnaruhadiksheerakasaya mentioned in Chikitsamanjari in Vataraktha context possess Vatapittapradhana Tridoshasamana, Rasarakthapradhaka, Dahasamana, Rasayana, Medhya, Balya like properties which can be beneficial in reducing the most wretched vasomotor symptoms. Apart from these, the formulation exhibits anti-oxidant, free radical scavenging, phytoestrogenic and anti-stress activity. Ksheera is Vata pitta samana, Rasayana, Sheeta veerya, Vrishya, Ojasyam, Dhatuvardhaka, and Jeevaneeya. For thirty days, 48ml of Shatavarichinnaruhadi ksheerakasaya was administered twice daily, one hour before food. The severity of symptoms particularly hot flushes and night sweats were considerably reduced after treatment. Thirty days after quitting the drug, a follow-up was conducted, and this time the severity of the symptoms was also less severe than it had been before therapy. From this case report, it is evident that Shatavarichinnaruhadi ksheerakasaya is effective for the management of perimenopausal symptoms especially the most disturbing vasomotor symptoms","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"42 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140743093","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To Evaluate the Clinical Efficacy of Darvyadi Churna in the Management of Madhumeha (Denovo Diabetes Mellitus) 评估 Darvyadi Churna 在治疗 Madhumeha(变性糖尿病)中的临床疗效
Pub Date : 2024-03-05 DOI: 10.47070/ijapr.v12i2.3137
G.Pavani, P.Srikanth Babu, K.Laxmikantham
Madhumeha, one among the Vataja Pramehas need utmost consideration in the current scenario in view of the rising incidence. Madhumeha is similar to diabetes mellitus. Diabetes Mellitus is a chronic metabolic disease characterized by elevated levels of blood glucose which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The most common is Type 2 Diabetes, usually in adults, which occurs when the body becomes resistant to Insulin or doesn't make enough Insulin. In the past 3 decades the prevalence of Type 2 Diabetes has raised dramatically in countries of all income levels. According to Ayurveda, Madhumeha is manageable with the prescribed Chikitsa in the Samhitas. It is judiciously managed with the help of Yuktikruta Ahara, Vihara and Aushadha (Darvyadi churna). In this case Nidana parivarjana has been followed and this case is being considered as Sthoola Pramehi.
Madhumeha 是 Vataja Pramehas 中的一种,在当前发病率不断上升的情况下,需要予以高度重视。Madhumeha 与糖尿病相似。糖尿病是一种慢性代谢疾病,其特点是血糖水平升高,随着时间的推移,会对心脏、血管、眼睛、肾脏和神经造成严重损害。最常见的是 2 型糖尿病,通常发生在成年人身上,当人体对胰岛素产生抵抗或不能制造足够的胰岛素时,就会患上 2 型糖尿病。在过去的 30 年里,2 型糖尿病的发病率在所有收入水平的国家都急剧上升。根据阿育吠陀,Madhumeha 可通过 Samhitas 中规定的 Chikitsa 进行控制。它可以在 Yuktikruta Ahara、Vihara 和 Aushadha(Darvyadi churna)的帮助下得到明智的控制。在这种情况下,Nidana parivarjana 得到了遵循,这种情况被视为 Sthoola Pramehi。
{"title":"To Evaluate the Clinical Efficacy of Darvyadi Churna in the Management of Madhumeha (Denovo Diabetes Mellitus)","authors":"G.Pavani, P.Srikanth Babu, K.Laxmikantham","doi":"10.47070/ijapr.v12i2.3137","DOIUrl":"https://doi.org/10.47070/ijapr.v12i2.3137","url":null,"abstract":"Madhumeha, one among the Vataja Pramehas need utmost consideration in the current scenario in view of the rising incidence. Madhumeha is similar to diabetes mellitus. Diabetes Mellitus is a chronic metabolic disease characterized by elevated levels of blood glucose which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves. The most common is Type 2 Diabetes, usually in adults, which occurs when the body becomes resistant to Insulin or doesn't make enough Insulin. In the past 3 decades the prevalence of Type 2 Diabetes has raised dramatically in countries of all income levels. According to Ayurveda, Madhumeha is manageable with the prescribed Chikitsa in the Samhitas. It is judiciously managed with the help of Yuktikruta Ahara, Vihara and Aushadha (Darvyadi churna). In this case Nidana parivarjana has been followed and this case is being considered as Sthoola Pramehi.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"356 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140397716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Ayurveda and Pharma Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1